Hydroxychloroquine for Treatment of Non-Severe COVID-19
NCT04860284
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
105
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Hydroxychloroquine tablets
Sponsor
Makerere University